EDMOND DE ROTHSCHILD (SUISSE) S.A. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD (SUISSE) S.A. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$1,424,000
+179.8%
499,000
+232.7%
0.48%
+198.8%
Q2 2015$509,000150,0000.16%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders